Stay updated on Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page.

Latest updates to the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedNapoli, Italy, 80131 has been changed to Naples, Italy, 80131. The revision label has been updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page revision updated from v3.4.1 to v3.4.2; this appears to be a minor version update with no user-facing content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check58 days agoChange DetectedAdded Primary peritoneal carcinoma to the Conditions and introduced a new Resources link to the Genetic and Rare Diseases Information Center. Page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check72 days agoChange Detected- Show glossary toggle added; - new study-record metadata appears (Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, Revision: v3.4.0), replacing older labels/versions. These changes affect UI labels and data disclosures but do not alter the core study details.SummaryDifference0.1%

- Check79 days agoChange DetectedA new revision tag, Revision: v3.3.4, was added and the previous Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Platinum Therapy With TSR-042 & Niraparib in Ovarian Cancer Clinical Trial page.